{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:02:08Z","timestamp":1783735328950,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.11.011","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T02:45:14Z","timestamp":1352515514000},"page":"545-552","source":"Crossref","is-referenced-by-count":22,"title":["TAT-mediated gp96 transduction to APCs enhances gp96-induced antiviral and antitumor T cell responses"],"prefix":"10.1016","volume":"31","author":[{"given":"Bao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songdong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (8)","key":"10.1016\/j.vaccine.2012.11.011_bib0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1586\/14760584.7.8.1185","article-title":"Heat-shock proteins as powerful weapons in vaccine development","volume":"7","author":"Bolhassani","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.011_bib0010","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/ijc.27332","article-title":"Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited","volume":"130","author":"Randazzo","year":"2012","journal-title":"Int J Cancer"},{"issue":"23","key":"10.1016\/j.vaccine.2012.11.011_bib0015","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1074\/jbc.M200425200","article-title":"The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2\/4 pathway","volume":"277","author":"Vabulas","year":"2002","journal-title":"J Biol Chem"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.11.011_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri1089","article-title":"Re-evaluating the role of heat-shock protein\u2013peptide interactions in tumour immunity","volume":"3","author":"Nicchitta","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"32","key":"10.1016\/j.vaccine.2012.11.011_bib0025","doi-asserted-by":"crossref","first-page":"22545","DOI":"10.1074\/jbc.M502900200","article-title":"Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses","volume":"281","author":"Warger","year":"2006","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.vaccine.2012.11.011_bib0030","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.4049\/jimmunol.0801563","article-title":"Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling","volume":"182","author":"Huang","year":"2009","journal-title":"J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.11.011_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1074-7613(01)00111-X","article-title":"CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin","volume":"14","author":"Basu","year":"2001","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.vaccine.2012.11.011_bib0040","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1093\/emboj\/cdg572","article-title":"Scavenger receptor-A mediates gp96\/GRP94 and calreticulin internalization by antigen-presenting cells","volume":"22","author":"Berwin","year":"2003","journal-title":"EMBO J"},{"issue":"16","key":"10.1016\/j.vaccine.2012.11.011_bib0045","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1073\/pnas.0308180101","article-title":"Essential role of CD91 in re-presentation of gp96-chaperoned peptides","volume":"101","author":"Binder","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.011_bib0050","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.4049\/jimmunol.181.9.6525","article-title":"Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses","volume":"81","author":"De Filippo","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.011_bib0055","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.4049\/jimmunol.180.5.3176","article-title":"Phylogenetic conservation of glycoprotein 96 ability to interact with CD91 and facilitate antigen cross-presentation","volume":"180","author":"Robert","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.11.011_bib0060","first-page":"7","article-title":"High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules","volume":"10","author":"Matsutake","year":"2010","journal-title":"Cancer Immun"},{"key":"10.1016\/j.vaccine.2012.11.011_bib0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ncomms1524","article-title":"CD91-dependent programming of T-helper cell responses following heat shock protein immunization","volume":"2","author":"Pawaria","year":"2011","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.011_bib0070","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.4049\/jimmunol.168.9.4282","article-title":"Cutting edge: CD91-independent cross-presentation of GRP94(gp96)-associated peptides","volume":"168","author":"Berwin","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.11.011_bib0075","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.4049\/jimmunol.1000448","article-title":"Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding uptake, and peptide cross-presentation","volume":"185","author":"Jockheck-Clark","year":"2010","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.11.011_bib0080","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.4049\/jimmunol.0901828","article-title":"Efficient cross-priming of antiviral CD8(+) T cells by antigen donor cells is GRP94 independent","volume":"183","author":"Lev","year":"2009","journal-title":"J Immunol"},{"issue":"August (2\u20133)","key":"10.1016\/j.vaccine.2012.11.011_bib0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-011-8221-2","article-title":"A role for the heat shock protein\u2013CD91 axis in the initiation of immune responses to tumors","volume":"50","author":"Pawaria","year":"2011","journal-title":"Immunol Res"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.11.011_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-6147(99)01429-7","article-title":"In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA","volume":"21","author":"Schwarze","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.011_bib0095","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.011_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.imlet.2009.10.011","article-title":"HBcAg18\u201327 epitope fused to HIV-Tat 49\u201357 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice","volume":"127","author":"Wang","year":"2010","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.011_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/cbt.11.1.13960","article-title":"Introduction of hypoxia-targeting p53 fusion protein for the selective therapy of non-small cell lung cancer","volume":"11","author":"Zhao","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"August (22)","key":"10.1016\/j.vaccine.2012.11.011_bib0110","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1016\/j.biomaterials.2011.03.058","article-title":"Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery","volume":"32","author":"Nam","year":"2011","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.011_bib0115","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/nn201369k","article-title":"Negotiation of intracellular membrane barriers by TAT-modified gold nanoparticles","volume":"5","author":"Krpetic","year":"2011","journal-title":"ACS Nano"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2012.11.011_bib0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00726-010-0534-2","article-title":"A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain","volume":"39","author":"Wu","year":"2010","journal-title":"Amino Acids"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.11.011_bib0125","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00262-011-1076-5","article-title":"Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity","volume":"60","author":"Yan","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.11.011_bib0130","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1002\/eji.200939593","article-title":"Treg suppress CTL responses upon immunization with HSP gp96","volume":"39","author":"Liu","year":"2009","journal-title":"Eur J Immunol"},{"issue":"37","key":"10.1016\/j.vaccine.2012.11.011_bib0135","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/j.vaccine.2011.05.008","article-title":"Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB\/c and transgenic mice","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.11.011_bib0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-1759(02)00093-5","article-title":"Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides","volume":"264","author":"Meng","year":"2002","journal-title":"J Immunol Methods"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2012.11.011_bib0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1471-4159.2005.03359.x","article-title":"TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death","volume":"95","author":"Soane","year":"2005","journal-title":"J Neurochem"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.11.011_bib0150","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/intimm\/9.8.1203","article-title":"DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes","volume":"9","author":"Kuhrober","year":"1997","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.11.011_bib0155","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.162.7.3915","article-title":"Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes","volume":"162","author":"Ishioka","year":"1999","journal-title":"J Immunol"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2012.11.011_bib0160","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1128\/JVI.76.17.8609-8620.2002","article-title":"Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections","volume":"76","author":"Kakimi","year":"2002","journal-title":"J Virol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.11.011_bib0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coi.2009.12.002","article-title":"Localisation and trafficking of Toll-like receptors: an important mode of regulation","volume":"22","author":"McGettrick","year":"2010","journal-title":"Curr Opin Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.11.011_bib0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jgm.1445","article-title":"GP96 C-terminal improves Her2\/neu DNA vaccine","volume":"12","author":"Pakravan","year":"2010","journal-title":"J Gene Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.11.011_bib0175","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/CVI.00160-09","article-title":"Glycoprotein 96-mediated presentation of human immunodeficiency virus type 1 (HIV-1)-specific human leukocyte antigen class I-restricted peptide and humoral immune responses to HIV-1 p24","volume":"16","author":"Gong","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2012.11.011_bib0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/fon.09.46","article-title":"Vitespen: a preclinical and clinical review","volume":"5","author":"Wood","year":"2009","journal-title":"Future Oncol"},{"issue":"18","key":"10.1016\/j.vaccine.2012.11.011_bib0185","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1074\/jbc.M501233200","article-title":"Testing the role of gp96 as peptide chaperone in antigen processing","volume":"280","author":"Demine","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.011_bib0190","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.4049\/jimmunol.179.4.2035","article-title":"Structure and function: heat shock proteins and adaptive immunity","volume":"179","author":"Javid","year":"2007","journal-title":"J Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2012.11.011_bib0195","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2010.03.070","article-title":"The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits hepatitis B virus replication in transgenic mice","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.11.011_bib0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/17425240902887029","article-title":"TAT-based drug delivery system \u2013 new directions in protein delivery for new hopes?","volume":"6","author":"Rapoport","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.011_bib0205","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1074\/jbc.M109.021964","article-title":"Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction","volume":"285","author":"Gump","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.011_bib0210","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/bi0016218","article-title":"Biophysical analysis of the endoplasmic reticulum-resident chaperone\/heat shock protein gp96\/GRP94 and its complex with peptide antigen","volume":"40","author":"Linderoth","year":"2001","journal-title":"Biochemistry (Mosc)"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.011_bib0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4049\/jimmunol.174.1.195","article-title":"Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments","volume":"174","author":"Li","year":"2005","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.vaccine.2012.11.011_bib0220","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1016\/j.vaccine.2008.03.082","article-title":"Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies","volume":"26","author":"Bolhassani","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.011_bib0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jbiotec.2010.12.006","article-title":"Hansenula polymorpha expressed heat shock protein gp96 exerts potent T cell activation activity as an adjuvant","volume":"151","author":"Li","year":"2011","journal-title":"J Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T14:27:57Z","timestamp":1687789677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12016040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12016040"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}